Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2015

Open Access 01-12-2015 | Meeting abstract

Perceptions of primary care professionals about sharing patient care with endocrinologist medium sized-city

Authors: Andrea CBB Duvoisin, Ricardo Larroyed de Oliveira, Elisabeth Maria Nardelli de Oliveira

Published in: Diabetology & Metabolic Syndrome | Special Issue 1/2015

Login to get access

Excerpt

General physicians in the Family Health Strategy assist most diabetic patients in medium sized-city according to the principles of primary health care. Although in recent yrs. there has been an increase in the number of Family Health teams, the numbers of hospitalizations for diabetes complication continue to arise in the city. …
Metadata
Title
Perceptions of primary care professionals about sharing patient care with endocrinologist medium sized-city
Authors
Andrea CBB Duvoisin
Ricardo Larroyed de Oliveira
Elisabeth Maria Nardelli de Oliveira
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue Special Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-7-S1-A181

Other articles of this Special Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine